FILE PHOTO: A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo
Want our Alerts FASTER than everyone else?
Serious traders know that every second counts in these markets. Text messages are about 7x faster than email. Get an edge on other traders by receiving our FREE instant Stock Alerts ahead of e-mail subscribers by subscribing to our Mobile Alert System.
We promise never to share your number with anyone else. Standard text messaging rates may apply.
